T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures.
It is becoming clear that during each developmental stage of pregnancy, different immunological conditions exist and may even be necessary for success. The widely accepted T helper (Th) 1 and 2 concept has some limitations if applied to the various developmental stages of pregnancy. During the implantation period, a multidirectional cytokine network is necessary with the blastocyst producing cytokines and other factors and the endometrium synthesizing factors necessary for the embryonic development. Improper immune responses and an unbalanced cytokine network may be related to implantation failures, pregnancy losses and obstetrical complications. A propensity to Th1 immune responses has been reported in these conditions systemically or locally. The presence of elevated Th1:Th2 cell ratios, high concentration of Th1 cytokines secreted by peripheral blood mononuclear cells, elevated NK cell cytotoxicity and levels, and emergence of various autoantibodies are the supporting evidence. The underlying immunopathology for the preponderance of Th1 is unknown. Genetic, environmental, and hormonal etiologies need to be explored further in the future. The purpose of this review is to give an overview of what is known about the immune response in women with reproductive failures and provide an update of some of the most recent findings in this field.
Kwak-Kim
Joanne Y H
JYH
Department of Obstetrics and Gynecology and Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science, Chicago Medical School, North Chicago, Ill., USA.
Gilman-Sachs
Alice
A
Kim
Caroline E
CE
D000026:Abortion, Habitual / Q000235:genetics / Q000276:immunology*; D000818:Animals; D010064:Embryo Implantation / Q000276:immunology*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000235:genetics / Q000276:immunology*; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000235:genetics; D018417:Th1 Cells / Q000276:immunology* / Q000378:metabolism; D018418:Th2 Cells / Q000276:immunology* / Q000378:metabolism